Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis P Garrison

Showing results (171-180 of 190) with videos related to

Pageof 19
Sort By:
Clinical Therapeutics|October 9, 2022
Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer DiseaseMalaz Boustani, Erin G Doty, Louis P Garrison, et al.
Transplantation|July 16, 2008
Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes researchSteven K Takemoto, Wolfgang Arns, Suphamai Bunnapradist, et al.
Journal of Managed Care & Specialty Pharmacy|March 25, 2015
Design, implementation, and first-year outcomes of a value-based drug formularySean D Sullivan, Kai Yeung, Carol Vogeler, et al.
Journal of Comparative Effectiveness Research|February 22, 2018
Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA FoundationEmily Beth Devine, Eleanor Perfetto, A Simon Pickard, et al.
Science (New York, N.Y.)|April 21, 2018
Insurance coverage for genomic testsKathryn A Phillips, Julia R Trosman, Patricia A Deverka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
International Society for Pharmacoeconomics and Outcomes Research Comments on the American Society of Clinical Oncology Value FrameworkDaniel C Malone, Nancy S Berg, Karl Claxton, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 19, 2017
Costs of integrating cervical cancer screening at an HIV clinic in KenyaElisabeth L Vodicka, Joseph B Babigumira, Marita R Mann, et al.
Eclinicalmedicine|June 4, 2020
Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan womenHoracio A Duarte, Joseph B Babigumira, Eva A Enns, et al.
The Oncologist|January 10, 2013
The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide maintenance treatmentLouis P Garrison, Si-Tien Wang, Hui Huang, et al.
Plos One|June 7, 2019
Estimating the costs of HIV clinic integrated versus non-integrated treatment of pre-cancerous cervical lesions and costs of cervical cancer treatment in KenyaElisabeth L Vodicka, Michael H Chung, Marita R Zimmermann, et al.
Pageof 19

Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
Clinical Therapeutics|October 9, 2022
Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer DiseaseMalaz Boustani, Erin G Doty, Louis P Garrison, et al.
Transplantation|July 16, 2008
Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes researchSteven K Takemoto, Wolfgang Arns, Suphamai Bunnapradist, et al.
Journal of Managed Care & Specialty Pharmacy|March 25, 2015
Design, implementation, and first-year outcomes of a value-based drug formularySean D Sullivan, Kai Yeung, Carol Vogeler, et al.
Journal of Comparative Effectiveness Research|February 22, 2018
Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA FoundationEmily Beth Devine, Eleanor Perfetto, A Simon Pickard, et al.
Science (New York, N.Y.)|April 21, 2018
Insurance coverage for genomic testsKathryn A Phillips, Julia R Trosman, Patricia A Deverka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
International Society for Pharmacoeconomics and Outcomes Research Comments on the American Society of Clinical Oncology Value FrameworkDaniel C Malone, Nancy S Berg, Karl Claxton, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 19, 2017
Costs of integrating cervical cancer screening at an HIV clinic in KenyaElisabeth L Vodicka, Joseph B Babigumira, Marita R Mann, et al.
Eclinicalmedicine|June 4, 2020
Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan womenHoracio A Duarte, Joseph B Babigumira, Eva A Enns, et al.
The Oncologist|January 10, 2013
The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide maintenance treatmentLouis P Garrison, Si-Tien Wang, Hui Huang, et al.
Plos One|June 7, 2019
Estimating the costs of HIV clinic integrated versus non-integrated treatment of pre-cancerous cervical lesions and costs of cervical cancer treatment in KenyaElisabeth L Vodicka, Michael H Chung, Marita R Zimmermann, et al.
Pageof 19